Neurological involvement in hospitalized children with SARS-CoV-2 infection : a multinational study
BACKGROUND AND OBJECTIVES: Neurological involvement associated with SARS-CoV-2 infection is increasingly recognized. However, the specific characteristics and prevalence in pediatric patients remain unclear. The objective of this study was to describe the neurological involvement in a multinational cohort of hospitalized pediatric patients with SARS-CoV-2.
METHODS: This was a multicenter observational study of children <18 years of age with confirmed SARS-CoV-2 infection or multisystemic inflammatory syndrome (MIS-C) and laboratory evidence of SARS-CoV-2 infection in children, admitted to 15 tertiary hospitals/healthcare centers in Canada, Costa Rica, and Iran February 2020-May 2021. Descriptive statistical analyses were performed and logistic regression was used to identify factors associated with neurological involvement.
RESULTS: One-hundred forty-seven (21%) of 697 hospitalized children with SARS-CoV-2 infection had neurological signs/symptoms. Headache (n = 103), encephalopathy (n = 28), and seizures (n = 30) were the most reported. Neurological signs/symptoms were significantly associated with ICU admission (OR: 1.71, 95% CI: 1.15-2.55; p = 0.008), satisfaction of MIS-C criteria (OR: 3.71, 95% CI: 2.46-5.59; p < 0.001), fever during hospitalization (OR: 2.15, 95% CI: 1.46-3.15; p < 0.001), and gastrointestinal involvement (OR: 2.31, 95% CI: 1.58-3.40; p < 0.001). Non-headache neurological manifestations were significantly associated with ICU admission (OR: 1.92, 95% CI: 1.08-3.42; p = 0.026), underlying neurological disorders (OR: 2.98, 95% CI: 1.49-5.97, p = 0.002), and a history of fever prior to hospital admission (OR: 2.76, 95% CI: 1.58-4.82; p < 0.001).
DISCUSSION: In this study, approximately 21% of hospitalized children with SARS-CoV-2 infection had neurological signs/symptoms. Future studies should focus on pathogenesis and long-term outcomes in these children.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:51 |
|---|---|
| Enthalten in: |
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques - 51(2024), 1 vom: 18. Jan., Seite 40-49 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 19.01.2024 Date Revised 19.01.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1017/cjn.2022.347 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM351084959 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM351084959 | ||
| 003 | DE-627 | ||
| 005 | 20240119231827.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1017/cjn.2022.347 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1264.xml |
| 035 | |a (DE-627)NLM351084959 | ||
| 035 | |a (NLM)36597285 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Yea, Carmen |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Neurological involvement in hospitalized children with SARS-CoV-2 infection |b a multinational study |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.01.2024 | ||
| 500 | |a Date Revised 19.01.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a BACKGROUND AND OBJECTIVES: Neurological involvement associated with SARS-CoV-2 infection is increasingly recognized. However, the specific characteristics and prevalence in pediatric patients remain unclear. The objective of this study was to describe the neurological involvement in a multinational cohort of hospitalized pediatric patients with SARS-CoV-2 | ||
| 520 | |a METHODS: This was a multicenter observational study of children <18 years of age with confirmed SARS-CoV-2 infection or multisystemic inflammatory syndrome (MIS-C) and laboratory evidence of SARS-CoV-2 infection in children, admitted to 15 tertiary hospitals/healthcare centers in Canada, Costa Rica, and Iran February 2020-May 2021. Descriptive statistical analyses were performed and logistic regression was used to identify factors associated with neurological involvement | ||
| 520 | |a RESULTS: One-hundred forty-seven (21%) of 697 hospitalized children with SARS-CoV-2 infection had neurological signs/symptoms. Headache (n = 103), encephalopathy (n = 28), and seizures (n = 30) were the most reported. Neurological signs/symptoms were significantly associated with ICU admission (OR: 1.71, 95% CI: 1.15-2.55; p = 0.008), satisfaction of MIS-C criteria (OR: 3.71, 95% CI: 2.46-5.59; p < 0.001), fever during hospitalization (OR: 2.15, 95% CI: 1.46-3.15; p < 0.001), and gastrointestinal involvement (OR: 2.31, 95% CI: 1.58-3.40; p < 0.001). Non-headache neurological manifestations were significantly associated with ICU admission (OR: 1.92, 95% CI: 1.08-3.42; p = 0.026), underlying neurological disorders (OR: 2.98, 95% CI: 1.49-5.97, p = 0.002), and a history of fever prior to hospital admission (OR: 2.76, 95% CI: 1.58-4.82; p < 0.001) | ||
| 520 | |a DISCUSSION: In this study, approximately 21% of hospitalized children with SARS-CoV-2 infection had neurological signs/symptoms. Future studies should focus on pathogenesis and long-term outcomes in these children | ||
| 650 | 4 | |a Observational Study | |
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Children | |
| 650 | 4 | |a Encephalopathy | |
| 650 | 4 | |a Neurologic | |
| 650 | 4 | |a Pediatrics | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a Seizures | |
| 700 | 1 | |a Barton, Michelle |e verfasserin |4 aut | |
| 700 | 1 | |a Bitnun, Ari |e verfasserin |4 aut | |
| 700 | 1 | |a Morris, Shaun K |e verfasserin |4 aut | |
| 700 | 1 | |a El Tal, Tala |e verfasserin |4 aut | |
| 700 | 1 | |a Ulloa-Gutierrez, Rolando |e verfasserin |4 aut | |
| 700 | 1 | |a Brenes-Chacon, Helena |e verfasserin |4 aut | |
| 700 | 1 | |a Yock-Corrales, Adriana |e verfasserin |4 aut | |
| 700 | 1 | |a Ivankovich-Escoto, Gabriela |e verfasserin |4 aut | |
| 700 | 1 | |a Soriano-Fallas, Alejandra |e verfasserin |4 aut | |
| 700 | 1 | |a Hernandez-de Mezerville, Marcela |e verfasserin |4 aut | |
| 700 | 1 | |a Gill, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Nateghian, Alireza |e verfasserin |4 aut | |
| 700 | 1 | |a Aski, Behzad Haghighi |e verfasserin |4 aut | |
| 700 | 1 | |a Manafi, Ali Anari |e verfasserin |4 aut | |
| 700 | 1 | |a Dwilow, Rachel |e verfasserin |4 aut | |
| 700 | 1 | |a Bullard, Jared |e verfasserin |4 aut | |
| 700 | 1 | |a Papenburg, Jesse |e verfasserin |4 aut | |
| 700 | 1 | |a Scuccimarri, Rosie |e verfasserin |4 aut | |
| 700 | 1 | |a Lefebvre, Marie-Astrid |e verfasserin |4 aut | |
| 700 | 1 | |a Cooke, Suzette |e verfasserin |4 aut | |
| 700 | 1 | |a Dewan, Tammie |e verfasserin |4 aut | |
| 700 | 1 | |a Restivo, Lea |e verfasserin |4 aut | |
| 700 | 1 | |a Lopez, Alison |e verfasserin |4 aut | |
| 700 | 1 | |a Sadarangani, Manish |e verfasserin |4 aut | |
| 700 | 1 | |a Roberts, Ashley |e verfasserin |4 aut | |
| 700 | 1 | |a Wong, Jacqueline |e verfasserin |4 aut | |
| 700 | 1 | |a Saux, Nicole Le |e verfasserin |4 aut | |
| 700 | 1 | |a Bowes, Jennifer |e verfasserin |4 aut | |
| 700 | 1 | |a Purewal, Rupeena |e verfasserin |4 aut | |
| 700 | 1 | |a Lautermilch, Janell |e verfasserin |4 aut | |
| 700 | 1 | |a Foo, Cheryl |e verfasserin |4 aut | |
| 700 | 1 | |a Merckx, Joanna |e verfasserin |4 aut | |
| 700 | 1 | |a Robinson, Joan |e verfasserin |4 aut | |
| 700 | 1 | |a Yeh, E Ann |e verfasserin |4 aut | |
| 700 | 0 | |a Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques |d 1974 |g 51(2024), 1 vom: 18. Jan., Seite 40-49 |w (DE-627)NLM00020014X |x 0317-1671 |7 nnns |
| 773 | 1 | 8 | |g volume:51 |g year:2024 |g number:1 |g day:18 |g month:01 |g pages:40-49 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1017/cjn.2022.347 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 51 |j 2024 |e 1 |b 18 |c 01 |h 40-49 | ||